Ebos GroupASX:EBO +0.64%77 Days Inventory is 41.48 as of Dec. 2025, which is 19% above its 10-year median of 34.98. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$32.93 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 115 Medical Distribution companies, Ebos Group ranks better than 63.48% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Ebos Group's Average Total Inventories for the
six
months ended in Dec. 2025 was A$1,351 Mil. Ebos Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was A$5,947 Mil.
Hence, Ebos Group's Days Inventory for the
six
months ended in Dec. 2025 was 41.48.
The historical rank and industry rank for Ebos Group's Days Inventory or its related term are showing as below:
ASX:EBO'
s Days Inventory Range Over the Past 10 Years
Min: 30.48 Med: 34.98 Max: 44.18
Current: 42.57
During the past 13 years, Ebos Group's highest Days Inventory was 44.18. The lowest was 30.48. And the median was 34.98.
ASX:EBO's Days Inventory is ranked better than 63.48% of 115
companies
in the Medical Distribution industry
Industry Median: 57.73
vs ASX:EBO: 42.57
Ebos Group's Days Inventory
declined
from Dec. 2024 (43.35) to Dec. 2025 (41.48).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ebos Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.40.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ebos Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.20.
Ebos Group (ASX:EBO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ebos Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ebos Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ebos Group Days Inventory Related Terms
Ebos Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Ebos Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EBO vs MCK, CAH, COR: Days Inventory Comparison
For the Medical Distribution subindustry, Ebos Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ebos Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a Days Inventory of 41.48 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ebos Group and its competitors. This is 19% above median its historical median of 34.98. Over the past decade, Ebos Group's Days Inventory has ranged from 30.48 to 44.18. According to the industry distribution chart, Ebos Group ranks #42 out of 115 companies in the Medical Distribution industry, placing it in the top 36.5%.
Is Ebos Group's Days Inventory too high?
Ebos Group's current Days Inventory of 41.48 is 19% above median its 10-year median of 34.98. Over the past 10 years, this metric has ranged from a low of 30.48 to a high of 44.18. The Medical Distribution industry median Days Inventory is 57.73. Ebos Group's value of 41.48 is 28.1% below this industry median. Based on the distribution chart, Ebos Group ranks #42 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Days Inventory compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #42 out of 115 companies for Days Inventory. This puts Ebos Group in the upper half of its industry. The industry median Days Inventory is 57.73. Ebos Group's value of 41.48 is 28.1% below this benchmark. Historically, Ebos Group's own Days Inventory has ranged from 30.48 to 44.18 over the past decade. While the company's 10-year median is 34.98 vs. the industry median of 57.73, Ebos Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.73, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current Days Inventory of 41.48 is 28.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current Days Inventory is 41.48, which is 19% above median its own 10-year median of 34.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$32.93, compared to a current price of A$17.18 — trading 47.8% below its estimated fair value. The current Days Inventory is 41.48, which is 19% above median its 10-year median of 34.98 and 28.1% below the Medical Distribution industry median of 57.73. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Days Inventory is 41.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$17.18 is trading 47.8% below its estimated GF Value™ of A$32.93.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
Days Inventory: 41.48 (19% above median its 10-year median of 34.98)
GF Value™: A$32.93 vs. price of A$17.18 (47.8% below fair value)
Industry Position: 28.1% below the Medical Distribution median (#42 of 115)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
